Stable heparin-producing cell lines derived from the Furth murine mastocytoma.
Stable cell lines that synthesize heparin have been established from the Furth murine mastocytoma. The parental line (MST) divides in suspension every 14-18 h in growth medium supplemented with fetal bovine serum or defined growth factors. Adherent subclones were selected by adhesion to plastic culture vessels. Both adherent and nonadherent cells contain about 0.4 micrograms of glycosaminoglycan hexuronic acid per 10(6) cells, composed of 80% heparin and 20% chondroitin sulfate E. Deaminative cleavage of MST heparin by HNO2 at pH 1.5 released disaccharides that were similar in composition to those obtained from commercial heparin, except that disaccharides containing 3,6-O-desulfated GlcN units were not found. Greater than 90% of the glycosaminoglycans were stored in cytoplasmic granules, and challenge of the cells with dinitrophenylated bovine serum albumin and anti-dinitrophenyl IgE released a portion of the stored material. Growth studies of subclones showed that MST cells tolerate a 10-fold variation in glycosaminoglycan content. Incubation of cells with sodium chlorate reduced glycosaminoglycan sulfation by > 95% without affecting cell growth. Thus, granule glycosaminoglycans appear to be nonessential for growth of MST cells.
Montgomery
R I
RI
Department of Biochemistry, School of Medicine, University of Alabama, Birmingham 35294.
Lidholt
K
K
Flay
N W
NW
Liang
J
J
Vertel
B
B
Lindahl
U
U
Esko
J D
JD
D000818:Animals; D002455:Cell Division; D002809:Chondroitin Sulfates / Q000096:biosynthesis*; D003594:Cytoplasmic Granules / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006493:Heparin / Q000096:biosynthesis*; D066298:In Vitro Techniques; D008407:Mast Cells / Q000166:cytology / Q000378:metabolism*; D012515:Mast-Cell Sarcoma / Q000473:pathology*; D051379:Mice; D008854:Microscopy, Electron; D014407:Tumor Cells, Cultured
D006025:Glycosaminoglycans; D006493:Heparin; D002809:Chondroitin Sulfates